Outsourcing in Clinical Trials Southern California 2021
In light of the recent global developments around the COVID-19 virus, we have made the unavoidable decision to postpone Outsourcing in Clinical Trials Southern California. The event will now take place on 7th & 8th December 2021.
Arena International are delighted to announce the return of Outsourcing in Clinical Trials Southern California this October for its 8th Annual event!
Our 2021 programme boasts two full streams;
- Clinical Operations & Outsourcing
- Clinical Trial Technology & Innovation
Attendees will hear from AbbVie, Pfizer, Arena Pharmaceuticals, Bristol Myers Squibb, ClearFlow, Daré Bioscience and many more. Mary Syto, Director of Early Clinical Development at Bristol Myers Squibb, will be leading the Clinical Operations stream, whilst James Wabby, Executive Director of Regulatory Affairs & Combination Products/Device at AbbVie, will be heading up the Innovation stream.
Whether you are interested in debating the long term impacts COVID-19 will have on the future of clinical trials, or you want to get stuck into a discussion on best practices for strong CRO communications and building trust, there is something for everyone.
With a more interactive and hands on agenda including debates, workshops, roundtables, fireside chats and more, this event will create an environment where clinical trial teams from across all sizes of sponsor and vendor can work together to manage demands while ensuring patients are safeguarded at all stages.
Don’t miss out; join us in La Jolla on December 7th & 8th 2021!
ATTENDEES AT DIRECTOR + LEVEL
Catalent solves today’s clinical trial challenges and develop innovative solutions for the future. Catalent’s commitment to quality and service excellence is evident in its flexible solutions, modern global facilities, and over 25 years’ experience reliably supplying thousands of studies of all sizes and complexities around the world.
Advanced Clinical is a global clinical research services organization, providing CRO, FSP, Strategic Resourcing and Consulting Services for biopharmaceutical and medical device organizations. Our company is committed to improving all lives touched by clinical research and we address the hopes of patients and healthcare professionals with industry-leading services and technology in life sciences. Visit our website to learn more about how we deliver a Better Clinical Experience.
With over 40 years’ experience, 600 beds and locations in NA, EU and Asia, Celerion conducts First-in-Human, clinical Proof-of-Concept and patient dose response studies, cardiovascular safety and NDA-enabling clinical pharmacology research. Celerion provides full study services including statistics, data management and biostatistics (including PK/PD analysis), and bioanalytical services.
CROMSOURCE is an international contract research organization providing a comprehensive services to the pharmaceutical and biotechnology companies. Specializing in clinical development and staffing solutions, we offer a flexible approach to ensure our clients’ unique needs are supported. CROMSOURCE is unparalleled in offering an end-to-end guarantee covering trial timelines, enrollment, and price. CROMSOURCE operates offices across Europe and North America.
KPS is a global, innovative, Clinical Outsourcing Provider delivering clinical trial monitoring, management and quality oversight services to pharmaceutical, biotechnology, medical device, and related industries. Founded and operated as a more customer centric and nimblealternative to traditional CROs, KPS offers a full range of services leveraging the latest clinical technologies.
Pharm-Olam International delivers cost effective, quality clinical services to pharma and biotech sponsors across all therapeutic areas in more than 40 countries. Since 1994, we have been committed to our objective: to create value for our clients by satisfying their clinical development needs with consistent and dependable solutions and services.